Join us online this Saturday, March 26, 9am
When it comes to innovation in neurology, Prof. Dr. med. Björn Falkenburger, Professor of Neurology at TU Dresden’s Department of Neurology, does not shy away from experiments or the practical questions they raise. From experimental therapies tested in his cell biology lab to healthcare technology, Prof. Dr. med. Falkenburger’s research is uniquely multi-level and particularly relevant in light of global health trends. His focus area, Parkinson’s disease (PD), is the fastest growing and second most common neurodegenerative disease worldwide. On Saturday, March 26 at 9am CET, Prof. Dr. med. Falkenburger will share exciting updates from the PD innovation space at this year’s Deutscher Kongress für Parkinson und Bewegungsstörungen 2022. What can attendees expect from his presentation?
A compelling case for digital technologies with a healthy dose of pragmatism, according Prof. Dr. med. Falkenburger. “We hope to inspire digital natives,” he says, while recognizing challenges of technology that are at the forefront of many attendees’ minds. Prof. Dr. med. Falkenburger’s presentation will provide welcome foresight needed to adapt to the changing tools and patients of the future.
The talk will draw on Prof. Dr. med. Falkenburger’s latest research on technological advances in Parkinson’s care. This research has informed his predictions for both healthcare providers and people living with Parkinson’s. Prof. Dr. med. Falkenburger believes doctors will be better connected and as a result have a more comprehensive understanding of their patients in the future. Treatments will be much more personalized than they are today, and doctors may ultimately understand why and how certain treatments were changed regardless of who made those choices. Advancements in our understanding of biological and digital biomarkers will play an integral role in this personalization and will allow for the development of new treatment options. On the patient side Prof. Dr. med. Falkenburger believes that people living with PD “Will be much more empowered than they are today. They will be better educated and will play a larger role in choosing and adapting their treatment options”.
Prof. Dr. med. Falkenburger will be presenting at this year’s Deutscher Kongress für Parkinson und Bewegungsstörungen 2022 on March 26 at 9am CET.
Join the discussion virtually to learn more about innovative digital technologies and discover how these advancements can be used to improve the quality of life for people living with neurodegenerative diseases. To register for the online event please visit: